
Nowadays, treatment selection for most types of zzso is based on zzso zzso and clinical criteria, which are zzso zzso by the selection criteria used in registration phase III zzso However, different zzso present distinct molecular features, so the current approach results in a lack of specificity of cancer therapy, which is associated with decreased efficacy and unnecessary zzso and zzso zzso zzso has proved able to predict the efficacy of selected targeted zzso This allows the selection of specific treatments for different types of cancer, increasing their zzso Even though the number of treatments for solid zzso that can be selected based on molecular diagnostic tools is zzso much effort is being put into the identification of new zzso This zzso reviews molecular diagnostic zzso that allow selection of specific therapies that have obtained regulatory approval as treatment of solid zzso 

